The latest data released by the Japanese government on the 19th showed that the number of people who completed the third dose of COVID-19 vaccine in Japan was 84911922, accounting for 67.4% of the total population.

The data shows that the number of people who have completed the first dose of COVID-19 vaccine in Japan accounts for 81.4% of the total population of the country; The number of people who completed the second inoculation accounted for 80.4% of the total population of the country. It is reported that Japan began to vaccinate COVID-19 vaccine against the variant strain of Omikjon in September this year, targeting people aged 12 and above who have received at least two doses of vaccine. According to the data, 37582513 people were vaccinated with COVID-19 vaccine against the variant strain of Omikjon, accounting for 29.8% of the total population of the country.

According to the Japanese Broadcasting Association TV reported on the 18th, due to the expansion of COVID-19 infection, the demand for fever and pain relievers is growing, and some medical institutions and pharmacies in Japan are short of fever and pain relievers. In this regard, the Ministry of Health, Labor and Welfare of Japan opened special windows for hospitals receiving patients with COVID-19 and pharmacies providing prescription drugs to help relevant institutions purchase drugs from suppliers with sufficient reserves. In addition, the Ministry of Health, Labor and Welfare also commissioned drug wholesale enterprises to give priority to the supply of small-scale pharmacies.

According to the statistics of the Ministry of Health, Labor and Welfare of Japan, 70921 new confirmed cases were added in Japan on the 19th, with a total of 27187394 confirmed cases; There were 180 new deaths, and the total number of deaths exceeded 53499. In Tokyo, 7949 new confirmed cases were reported on the same day, which exceeded the same period of the previous week for 14 consecutive days.